N
Nakorn Premsri
Researcher at Thailand Ministry of Public Health
Publications - 14
Citations - 3240
Nakorn Premsri is an academic researcher from Thailand Ministry of Public Health. The author has contributed to research in topics: Vaccination & Vaccine trial. The author has an hindex of 8, co-authored 10 publications receiving 3062 citations.
Papers
More filters
Journal ArticleDOI
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm,Punnee Pitisuttithum,Sorachai Nitayaphan,Jaranit Kaewkungwal,Joseph Chiu,Robert Paris,Nakorn Premsri,Chawetsan Namwat,Mark de Souza,Elizabeth Adams,Michael Benenson,Sanjay Gurunathan,Jim Tartaglia,John G. McNeil,Donald P. Francis,Donald Stablein,Deborah L. Birx,Supamit Chunsuttiwat,Chirasak Khamboonruang,Prasert Thongcharoen,Merlin L. Robb,Nelson L. Michael,Prayura Kunasol,Jerome H. Kim +23 more
TL;DR: This ALVAC-HIV and AIDSVAX B/E vaccine regimen may reduce the risk of HIV infection in a community-based population with largely heterosexual risk and offer insight for future research.
Journal ArticleDOI
Epidemiology and Burden of Rotavirus Diarrhea in Thailand: Results of Sentinel Surveillance
Chuleeporn Jiraphongsa,Joseph S. Bresee,Yaowapa Pongsuwanna,Pipat Kluabwang,Urai Poonawagul,Pramote Arporntip,Manas Kanoksil,Nakorn Premsri,Utcharee Intusoma +8 more
TL;DR: Community surveillance showed the proportion of cases of rotavirus diarrhea in the community to be much lower than that in the hospitalized population (12.2% vs. 43.0%) and the rotvirus serotypes now circulating in Thailand to be predominant each year.
Journal ArticleDOI
Extended Evaluation of the Virologic, Immunologic, and Clinical Course of Volunteers Who Acquired HIV-1 Infection in a Phase III Vaccine Trial of ALVAC-HIV and AIDSVAX B/E
Supachai Rerks-Ngarm,Robert Paris,Supamit Chunsutthiwat,Nakorn Premsri,Chawetsan Namwat,Chureeratana Bowonwatanuwong,Shuying S. Li,Jaranit Kaewkungkal,Rapee Trichavaroj,Nampueng Churikanont,Mark de Souza,Charla Andrews,Donald P. Francis,Elizabeth Adams,Jorge Flores,Sanjay Gurunathan,Jim Tartaglia,Robert J. O'Connell,Chirapa Eamsila,Sorachai Nitayaphan,Viseth Ngauy,Prasert Thongcharoen,Prayura Kunasol,Nelson L. Michael,Merlin L. Robb,Peter B. Gilbert,Jerome H. Kim +26 more
TL;DR: Vaccination did not affect the clinical course of HIV disease after infection and a potential vaccine effect on the genital mucosa warrants further study.
Journal ArticleDOI
Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.
Supachai Rerks-Ngarm,Punnee Pitisuttithum,Jean-Louis Excler,Jean-Louis Excler,Sorachai Nitayaphan,Jaranit Kaewkungwal,Nakorn Premsri,Prayura Kunasol,Nicos Karasavvas,Alexandra Schuetz,Alexandra Schuetz,Viseth Ngauy,Faruk Sinangil,Peter Dawson,Allan C. deCamp,Sanjay Phogat,Sanjay Garunathan,James Tartaglia,Carlos A. DiazGranados,Silvia Ratto-Kim,Poonam Pegu,Poonam Pegu,Michael A. Eller,Michael A. Eller,Chitraporn Karnasuta,David C. Montefiori,David C. Montefiori,Sheetal Sawant,Nathan Vandergrift,Saintedym Wills,Georgia D. Tomaras,Merlin L. Robb,Merlin L. Robb,Nelson L. Michael,Jerome H. Kim,Sandhya Vasan,Sandhya Vasan,Robert J. O'Connell,Rv Study Team +38 more
TL;DR: In RV144 vaccinees, AIDSVAX B/E with or without ALVAC-HIV 6-8 years after initial vaccination generated higher humoral responses than after RV144, but these responses were short-lived, and their magnitude did not increase with subsequent boost.
Journal ArticleDOI
Molecular Evolution of the HIV-1 Thai Epidemic between the Time of RV144 Immunogen Selection to the Execution of the Vaccine Efficacy Trial
Gustavo H. Kijak,Gustavo H. Kijak,Sodsai Tovanabutra,Sodsai Tovanabutra,Supachai Rerks-Ngarm,Sorachai Nitayaphan,Chirapa Eamsila,Prayura Kunasol,Chirasak Khamboonruang,Prasert Thongcharoen,Chawetsan Namwat,Nakorn Premsri,Michael Benenson,Patricia Morgan,Meera Bose,Meera Bose,Eric Sanders-Buell,Eric Sanders-Buell,Robert Paris,Merlin L. Robb,Merlin L. Robb,Deborah L. Birx,Mark de Souza,Francine E. McCutchan,Francine E. McCutchan,Nelson L. Michael,Jerome H. Kim +26 more
TL;DR: An overall increase in the genetic complexity of viruses in the Thai epidemic and in the distance to vaccine immunogens is shown, which should be considered at the time of the analysis of the trial results.